skip to main content
Visitante
Meu Espaço
Minha Conta
Sair
Identificação
This feature requires javascript
Tags
Revistas Eletrônicas (eJournals)
Livros Eletrônicos (eBooks)
Bases de Dados
Bibliotecas USP
Ajuda
Ajuda
Idioma:
Inglês
Espanhol
Português
This feature required javascript
This feature requires javascript
Primo Search
Busca Geral
Busca Geral
Acervo Físico
Acervo Físico
Produção Intelectual da USP
Produção USP
Search For:
Clear Search Box
Search in:
Busca Geral
Or hit Enter to replace search target
Or select another collection:
Search in:
Busca Geral
Busca Avançada
Busca por Índices
This feature requires javascript
This feature requires javascript
Serum Levels of Second Component of Complement in Cancer Patients
Southam
, Chester M ; Siegel, Alice
H
The Journal of immunology (1950), 1966-09, Vol.97 (3), p.331-337
[Periódico revisado por pares]
United States: Am Assoc Immnol
Texto completo disponível
Citações
Citado por
Exibir Online
Detalhes
Resenhas & Tags
Mais Opções
Nº de Citações
This feature requires javascript
Enviar para
Adicionar ao Meu Espaço
Remover do Meu Espaço
E-mail (máximo 30 registros por vez)
Imprimir
Link permanente
Referência
EasyBib
EndNote
RefWorks
del.icio.us
Exportar RIS
Exportar BibTeX
This feature requires javascript
Título:
Serum Levels of Second Component of Complement in Cancer Patients
Autor:
Southam
, Chester M
;
Siegel, Alice
H
Assuntos:
Adenocarcinoma - immunology
;
Carcinoma, Squamous Cell - immunology
;
Complement System Proteins
;
Hemolysis
;
Hodgkin Disease - immunology
;
Humans
;
Leukemia - immunology
;
Lymphoma, Large B-Cell, Diffuse - immunology
;
Lymphoma, Non-Hodgkin - immunology
;
Multiple Myeloma - immunology
;
Neoplasms - immunology
;
Sarcoma - immunology
É parte de:
The Journal of immunology (1950), 1966-09, Vol.97 (3), p.331-337
Notas:
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição:
Summary The levels of the second component of complement (C′2) in the serum of cancer patients were determined. The average of C′2 titers in the cancer group was slightly higher than in the healthy control group but the differences were not statistically significant. Among patients with lymphosarcoma and reticulum cell sarcoma, a few had very low C′2 levels, and all patients with Hodgkin's disease and multiple myeloma had moderately high levels. The biologic significance of these differences is obscure. They are not explained by such variables as technique, sex, age or therapy. Impending death was often, but not consistently, associated with low C′2 levels. In a small group of patients with various non-neoplastic diseases the only abnormality of note was a very low C′2 titer in a patient with lupus erythematosus.
Editor:
United States: Am Assoc Immnol
Idioma:
Inglês
Links
View this record in MEDLINE/PubMed
This feature requires javascript
This feature requires javascript
Voltar para lista de resultados
Anterior
Resultado
7
Avançar
This feature requires javascript
This feature requires javascript
Buscando em bases de dados remotas. Favor aguardar.
Buscando por
em
scope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
Mostrar o que foi encontrado até o momento
This feature requires javascript
This feature requires javascript
Anterior
Página Inicial
RSS
Feed
Políticas
Fale Conosco
Logos de Redes Sociais: 
Logos de Redes Sociais: